Coca-Cola and eight other sugary drink makers, including Rivella and Ramseier, signed an agreement to cut the sugar content of the products they sell in Switzerland by 10% between now and the end of 2024, under pressure from the government and health sector.
Although not legally binding, the Swiss agreement hailed the agreement as progress.
Drinks account for over 38 percent of the added sugars in the food and beverages consumed in Switzerland.
Over 100 grams of sugar are consumed daily on average by Swiss citizens, which is twice the amount advised by the World Health Organization.
Consuming too much sugar raises your risk of developing diabetes, obesity, and cardiovascular disease, which are the top killers in Switzerland. Nonetheless, it is difficult to stop and addictive.


Chinese Robotaxi Stocks Rally as Tesla Boosts Autonomous Driving Optimism
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
Singapore Growth Outlook Brightens for 2025 as Economists Flag AI and Geopolitical Risks
Silver Prices Hit Record High as Safe-Haven Demand Surges Amid U.S. Economic Uncertainty
Britain has almost 1 million young people not in work or education – here’s what evidence shows can change that
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions
Locked up then locked out: how NZ’s bank rules make life for ex-prisoners even harder
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
The Beauty Beneath the Expressway: A Journey from Self to Service
Gold and Silver Prices Dip as Markets Await Key U.S. Economic Data
The pandemic is still disrupting young people’s careers
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence 



